St. Jude Medical (STJ): Price Target and June Short Interest Disclosure

St. Jude Medical (STJ) : 18 investment research analysts covering St. Jude Medical (STJ) have an average price target of $74.08 for the near short term. The highest target price given by the Brokerage Firm to the stock is $91 and the lowest target is $54 for the short term. Analysts expect the variance to be within $11.77 of the average price.

St. Jude Medical (STJ) has shown a rise of 5.3% or 412,198 shares in the short positions. The bets have increased to 8,255,045 shares on June 30,2016 from 7,842,847 shares on June 15,2016. With respect to the floated shares, the shorts are 3%. The days to cover are calculated to be 3, using the standard per day volume of 3,030,945 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 12th.

Also, Equity Analysts at the Brokerage Firm, Barclays, downgrades their rating on the shares of St. Jude Medical (NYSE:STJ). Barclays has a Equal-weight rating on the shares. Previously, the analysts had a Overweight rating on the shares. As per the latest research report, the brokerage house raises the price target to $80 per share from a prior target of $74. The rating by the firm was issued on May 11, 2016.


St. Jude Medical (NYSE:STJ): stock turned positive on Thursday. Though the stock opened at $80.59, the bulls momentum made the stock top out at $80.91 level for the day. The stock recorded a low of $80.49 and closed the trading day at $80.73, in the green by 0.35%. The total traded volume for the day was 2,111,632. The stock had closed at $80.45 in the previous days trading.

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.